Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Interpolymer is a specialty chemical company focused on the development of advanced water-based polymer technologies for the life sciences and industrial sectors. Following its acquisition by Zschimmer & Schwarz in 2015, the company has continued to provide high-performance polymers used in personal care, pharmaceutical film coatings, and medical device applications. Their proprietary Syntran technology platform offers a range of film-formers and rheology modifiers that enhance the stability and delivery of active ingredients. With a global presence and a strong emphasis on R&D, Interpolymer serves as a key supplier of functional materials to the healthcare and cosmetic industries. The company's expertise in emulsion polymerization allows for the creation of tailored polymer architectures that meet specific regulatory and performance requirements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Interpolymer.